Efficacy News and Research

RSS
Advaxis commences enrollment in ADXS-HPV Phase 1/2 study for head and neck cancer

Advaxis commences enrollment in ADXS-HPV Phase 1/2 study for head and neck cancer

Amakem presents key preclinical data on AMA0076 at ARVO meeting

Amakem presents key preclinical data on AMA0076 at ARVO meeting

Metformin blocks uveitis in laboratory rats

Metformin blocks uveitis in laboratory rats

Oral zinc treatments may shorten duration of common cold symptoms in adults

Oral zinc treatments may shorten duration of common cold symptoms in adults

Halozyme first quarter net loss increases to $15.1 million

Halozyme first quarter net loss increases to $15.1 million

Pall in-line filters can reduce severe complications, length of hospital stay in PICU

Pall in-line filters can reduce severe complications, length of hospital stay in PICU

Salix first quarter total product revenue increases 62% to $171.1M

Salix first quarter total product revenue increases 62% to $171.1M

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Options for improving antimicrobial use in food animal production

Options for improving antimicrobial use in food animal production

NovaDigm reports positive data from Phase 1 NDV-3 vaccine program

NovaDigm reports positive data from Phase 1 NDV-3 vaccine program

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

BioCryst first quarter revenues increase to $12.2 million

BioCryst first quarter revenues increase to $12.2 million

Brain networks may avoid traffic jams by communicating on different frequencies

Brain networks may avoid traffic jams by communicating on different frequencies

Study reveals steepest decline in HPV vaccine completion among girls

Study reveals steepest decline in HPV vaccine completion among girls

Clinical data from Anacor’s tavaborole and AN2728 study to be presented at upcoming meetings

Clinical data from Anacor’s tavaborole and AN2728 study to be presented at upcoming meetings

Ocular Therapeutix initiates travoprost-loaded punctum plug trial in glaucoma

Ocular Therapeutix initiates travoprost-loaded punctum plug trial in glaucoma

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Pfizer terminates Lyrica Phase 3 trial on neuropathic pain associated with HIV neuropathy

Pfizer terminates Lyrica Phase 3 trial on neuropathic pain associated with HIV neuropathy

Isis commences ISIS-APOCIIIRx Phase 2 study in hypertriglyceridemia

Isis commences ISIS-APOCIIIRx Phase 2 study in hypertriglyceridemia

Pfizer’s Lyrica Phase 3 study on pDPN fails to meet primary endpoint

Pfizer’s Lyrica Phase 3 study on pDPN fails to meet primary endpoint

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.